At a glance
- Originator National Institutes of Health (USA)
- Class Antidepressants; Antiepileptic drugs; Antineoplastics; Neuroprotectants; Nootropics
- Mechanism of Action Glycine gated NMDA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Stroke